As shown in Figure 1, the case patients' sera (n = 305) were all initially applied to the conventional aCL and aβ2‐GPI antibody tests, which are recognized as two of the screening experiments for APS patients. This evidence concerns the gene GPI and autoimmune polyendocrinopathy.